Brii Biosciences Limited (HKG:2137)
1.380
+0.040 (2.99%)
May 7, 2026, 4:08 PM HKT
Brii Biosciences Employees
Brii Biosciences had 75 employees as of December 31, 2025. The number of employees decreased by 23 or -23.47% compared to the previous year.
Employees
75
Change
-23
Growth
-23.47%
Revenue / Employee
527.44K HKD
Profits / Employee
-3.30M HKD
Market Cap
996.03M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 75 | -23 | -23.47% |
| Jun 30, 2025 | 96 | - | - |
| Dec 31, 2024 | 98 | -30 | -23.44% |
| Dec 31, 2023 | 128 | -18 | -12.33% |
| Dec 31, 2022 | 146 | 33 | 29.20% |
| Dec 31, 2021 | 113 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| JW (Cayman) Therapeutics Co. | 314 |
| Zhaoke Ophthalmology | 276 |
| 3D Medicines | 162 |
| Transcenta Holding | 155 |
| Beijing Biostar Pharmaceuticals | 131 |
| Sunho Biologics | 128 |
| Kintor Pharmaceutical | 123 |
| Wuhan YZY Biopharma | 106 |
Brii Biosciences News
- 11 days ago - Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026 - PRNewsWire
- 6 weeks ago - Brii Biosciences Earnings Call Transcript: H2 2025 - Transcripts
- 7 weeks ago - Brii Biosciences Provides Corporate Updates and Reports Full Year 2025 Financial Results - PRNewsWire
- 6 months ago - Brii Biosciences Announces Publication of Phase 2 ENSURE Study Results in Nature Medicine - PRNewsWire
- 9 months ago - Brii Biosciences Earnings Call Transcript: H1 2025 - Transcripts
- 9 months ago - Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results - PRNewsWire
- 10 months ago - Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China - PRNewsWire
- 1 year ago - Brii Bio Presents Late-Breaking Data from Its Ongoing Phase 2 ENSURE Study at EASL Congress 2025, Suggesting BRII-179's Role in Advancing Higher HBsAg Loss - PRNewsWire